Fabian Schmidt

Laboratory of Retrovirology, The Rockefeller University

Affiliated withThe Rockefeller University King Abdullah University of Science and Technology (KAUST)

Research Area

Biography

Fabian Schmidt has not added Biography.
If you are Fabian Schmidt and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 12	2023

Other Publications

Article	Year
HIV-1-induced AIDS in monkeys. Science (New York, N.Y.)\| PubMed ID: 24948736	2014
Derivation of simian tropic HIV-1 infectious clone reveals virus adaptation to a new host. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 31048506	2019
Vesicular Stomatitis Virus Transcription Is Inhibited by TRIM69 in the Interferon-Induced Antiviral State. Journal of virology\| PubMed ID: 31578292	2019
Rhabdo-immunodeficiency virus, a murine model of acute HIV-1 infection. eLife\| PubMed ID: 31644426	2019
Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals. bioRxiv : the preprint server for biology\| PubMed ID: 32511384	2020
Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature\| PubMed ID: 32555388	2020
Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies. bioRxiv : the preprint server for biology\| PubMed ID: 32577645	2020
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses. bioRxiv : the preprint server for biology\| PubMed ID: 32577658	2020
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID19 Patients. medRxiv : the preprint server for health sciences\| PubMed ID: 32577675	2020
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies. Cell\| PubMed ID: 32645326	2020
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses. The Journal of experimental medicine\| PubMed ID: 32692348	2020
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients. Journal of clinical microbiology\| PubMed ID: 32917729	2020
Antibody potency, effector function and combinations in protection from SARS-CoV-2 infection . bioRxiv : the preprint server for biology\| PubMed ID: 32995782	2020
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. eLife\| PubMed ID: 33112236	2020
Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo. The Journal of experimental medicine\| PubMed ID: 33211088	2021
Evolution of antibody immunity to SARS-CoV-2. Nature\| PubMed ID: 33461210	2021
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature\| PubMed ID: 33567448	2021
Mutational escape from the polyclonal antibody response to SARS-CoV-2 infection is largely shaped by a single class of antibodies. bioRxiv : the preprint server for biology\| PubMed ID: 33758856	2021
Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies. bioRxiv : the preprint server for biology\| PubMed ID: 33758864	2021
Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2. bioRxiv : the preprint server for biology\| PubMed ID: 33851164	2021
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies. bioRxiv : the preprint server for biology\| PubMed ID: 33948592	2021
Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants. Nature\| PubMed ID: 34098567	2021
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection. Nature\| PubMed ID: 34126625	2021
Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies. Nature communications\| PubMed ID: 34234131	2021
Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: implications for the ability of serological assays to predict immunity. medRxiv : the preprint server for health sciences\| PubMed ID: 34268524	2021
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations. Immunity\| PubMed ID: 34331873	2021
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies. Cell reports\| PubMed ID: 34534459	2021
High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape. Nature\| PubMed ID: 34544114	2021
Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination. Nature\| PubMed ID: 34619745	2021
Replication and single-cycle delivery of SARS-CoV-2 replicons. Science (New York, N.Y.)\| PubMed ID: 34648371	2021
Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations. Nature immunology\| PubMed ID: 34716452	2021
Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape. eLife\| PubMed ID: 34874007	2021
Plasma neutralization properties of the SARS-CoV-2 Omicron variant. medRxiv : the preprint server for health sciences\| PubMed ID: 34931199	2021
Conserved Neutralizing Epitopes on the N-Terminal Domain of Variant SARS-CoV-2 Spike Proteins. bioRxiv : the preprint server for biology\| PubMed ID: 35132412	2022
Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost. Nature\| PubMed ID: 35447027	2022
Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins. Immunity\| PubMed ID: 35447092	2022
Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: a serological analysis. The Lancet. Microbe\| PubMed ID: 35636436	2022
Antibody evolution to SARS-CoV-2 after single-dose Ad26.COV2.S vaccine in humans. The Journal of experimental medicine\| PubMed ID: 35776090	2022
Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization After Messenger RNA Vaccination and Variant Breakthrough Infection. Open forum infectious diseases\| PubMed ID: 35818364	2022
Gut microbiota-derived metabolites confer protection against SARS-CoV-2 infection. Gut microbes\| PubMed ID: 35915556	2022
Antibody feedback regulation of memory B cell development in SARS-CoV-2 mRNA vaccination. medRxiv : the preprint server for health sciences\| PubMed ID: 35982682	2022
Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape. bioRxiv : the preprint server for biology\| PubMed ID: 36032981	2022
Memory B cell responses to Omicron subvariants after SARS-CoV-2 mRNA breakthrough infection in humans. The Journal of experimental medicine\| PubMed ID: 36149398	2022
Antibody feedback regulates immune memory after SARS-CoV-2 mRNA vaccination. Nature\| PubMed ID: 36473496	2023
Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape. Nature communications\| PubMed ID: 36653360	2023